700
Participants
Start Date
August 23, 2024
Primary Completion Date
April 27, 2027
Study Completion Date
April 27, 2027
Dapagliflozin
Dapagliflozin by oral administration
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Changchun
RECRUITING
Research Site, Jilin
RECRUITING
Research Site, Harbin
RECRUITING
Research Site, Shanghai
RECRUITING
Research Site, Nanjing
RECRUITING
Research Site, Wuxi
RECRUITING
Research Site, Suzhou
RECRUITING
Research Site, Huaian
RECRUITING
Research Site, Hefei
RECRUITING
Research Site, Fuyang
RECRUITING
Research Site, Fuyang
RECRUITING
Research Site, Wuhu
RECRUITING
Research Site, Jinan
RECRUITING
Research Site, Taian
RECRUITING
Research Site, Jining
RECRUITING
Research Site, Linyi
RECRUITING
Research Site, Tianjin
RECRUITING
Research Site, Ningbo
RECRUITING
Research Site, Nanchang
RECRUITING
Research Site, Ganzhou
TERMINATED
Research Site, Fuzhou
RECRUITING
Research Site, Xiamen
WITHDRAWN
Research Site, Changsha
RECRUITING
Research Site, Hengyang
NOT_YET_RECRUITING
Research Site, Zhumadian
RECRUITING
Research Site, Huizhou
RECRUITING
Research Site, Shenzhen
RECRUITING
Research Site, Dongguan
RECRUITING
Research Site, Foshan
RECRUITING
Research Site, Nanning
RECRUITING
Research Site, Xi'an
RECRUITING
Research Site, Lanzhou
Lead Sponsor
AstraZeneca
INDUSTRY